Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.
about
The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort studyAssociation between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysisGastrointestinal events and association with initiation of treatment for osteoporosis.Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment.Osteoporosis treatment: why ibandronic acid?The use of bisphosphonates in women: when to use and when to stop.Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study.Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route.
P2860
Q34678657-29B7DAAA-911E-4657-88F2-5C087672517AQ36006735-4809FB22-6DC9-4CA9-A2BD-31829EAE61BAQ36332223-00B390C8-EEBC-4725-9EE8-663D1449C779Q37388453-007176C7-4F37-432A-A8D5-D61832F1AF2CQ38104738-12520CDF-37FF-418A-94F8-63EBDCA63837Q38584336-37F7A551-C676-4F87-844F-648502C4856BQ41039515-D91CE3AD-6B68-4076-9D44-2A81FABDC1DAQ44948925-0A13176A-4357-4095-AA8D-BE67AD1CCEB8Q45377441-0C7D62F4-8418-4D2F-8439-EEA7A58BBDBD
P2860
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Risk of severe gastrointestina ...... y alendronate and risedronate.
@en
Risk of severe gastrointestina ...... y alendronate and risedronate.
@nl
type
label
Risk of severe gastrointestina ...... y alendronate and risedronate.
@en
Risk of severe gastrointestina ...... y alendronate and risedronate.
@nl
prefLabel
Risk of severe gastrointestina ...... y alendronate and risedronate.
@en
Risk of severe gastrointestina ...... y alendronate and risedronate.
@nl
P2093
P2860
P356
P1476
Risk of severe gastrointestina ...... y alendronate and risedronate.
@en
P2093
Liping Huang
Raymond E Cole
Steven T Harris
Stuart L Silverman
William A Blumentals
P2860
P304
P356
10.1345/APH.1L555
P407
P577
2009-03-24T00:00:00Z